Raia Drogasil (OTCMKTS:RADLY – Get Free Report) is anticipated to post its results after the market closes on Tuesday, August 4th. Analysts expect the company to post earnings of $0.0468 per share and revenue of $2.3159 billion for the quarter.
Raia Drogasil Trading Up 3.4%
RADLY opened at $3.68 on Friday. Raia Drogasil has a one year low of $2.47 and a one year high of $5.34. The business’s fifty day moving average is $3.56 and its two-hundred day moving average is $4.24.
Wall Street Analyst Weigh In
Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a research note on Thursday, April 9th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, Raia Drogasil has an average rating of “Hold”.
About Raia Drogasil
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Read More
- Five stocks we like better than Raia Drogasil
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
